Nvidia At $1 Trillion In Annual Sales? Raymond James Says It’s Possible By 2029
Raymond James says Nvidia could reach $1 trillion in annual sales by fiscal 2029 as AI demand stays strong and supply constraints ease.
Read original at benzingaEconomy · News reference
Dow Jumps 150 Points Following Producer Inflation Data: Investor Sentiment Improves, Fear & Greed Index In ‘Neutral’ Zone
U.S. stocks gain, led by Amazon and Alphabet. Apple hits record high. Aehr Test Systems and Morgan Stanley report strong earnings. PPI data cools inflation fears.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 16, 2026, 7:17 AM
- Checked
- Jul 16, 2026, 7:17 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Nvidia's Unusual Move Answers AI Trade’s Key Question; $40 Trillion US Debt Bomb Ticks; Key Fed Speech Awaited
Nvidia’s Unusual Move Please click here for an enlarged chart of NVIDIA Corp (NASDAQ:NVDA). Note the following: The chart shows that NVDA gapped up above the low band of Zone 1 (resistance). RSI on the
Read original at benzingaGreg Abel Has Kept 60% of Berkshire's $359 Billion Stock Portfolio in Just 5 Companies, Even After Eliminating 16 Other Positions in His First Quarter. Is That Concentration a Risk for Shareholders?
Since becoming CEO of Berkshire Hathaway, Greg Abel has maintained high concentration in five blue-chip stocks (Apple, American Express, Alphabet, Bank of America, and Coca-Cola), which now represent 60% of the portfolio. While this concentration is largely inherited from Warren Buffett's long-term investments, the article argues that downside risk is manageable given Berkshire's strong financial position. The greater concern is whether Abel can match Buffett's stock selection track record going forward.
Read original at the-motley-foolMAGS Is Treading Water This Year. Here's Why the Smartest Investors Are Still Buying.
The Roundhill Magnificent Seven ETF (MAGS) has underperformed major indexes year-to-date, up only 2% compared to the S&P 500 and Nasdaq's 12% gains. Despite this, investors remain interested due to five of the seven megacap stocks trading at below-average valuations. The concentrated portfolio carries higher volatility risk but offers potential for outperformance when markets rally.
Read original at the-motley-foolGlobal Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight
The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.
Read original at globenewswire-incLaboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS Insider
The global laboratory informatics market is projected to grow at a CAGR of 5.06% from 2025 to 2035, driven by increased data processing demands, regulatory compliance requirements, and adoption of cloud-native solutions and AI-driven analytics. North America leads with 42.55% market share, while Asia-Pacific is the fastest-growing region. Services and LIMS products dominate, with cloud delivery and electronic lab notebooks showing the strongest growth rates.
Read original at globenewswire-inc